Decoy Therapeutics Inc. Shares Outstanding (Cover Page)
Decoy Therapeutics Inc. (DCOY) had Shares Outstanding (Cover Page) of 655.18 thousand shares as of 2026-08-12, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-12: Entity Common Stock, Shares Outstanding 655.18K shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 531.97K shares.
- 2026-03-17: Entity Common Stock, Shares Outstanding 531.97K shares.
- 2025-11-12: Entity Common Stock, Shares Outstanding 5.86M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-12 | 655.18K shares 10-Q · filed 2026-08-12 |
| 2026-05-07 | 531.97K shares 10-Q · filed 2026-05-08 |
| 2026-03-17 | 531.97K shares 10-K · filed 2026-03-31 |
| 2025-11-12 | 5.86M shares 10-Q · filed 2025-11-14 |
| 2025-08-11 | 7.65M shares 10-Q · filed 2025-08-12 |
| 2025-05-09 | 2.13M shares 10-Q · filed 2025-05-14 |
| 2025-03-17 | 1.75M shares 10-K · filed 2025-03-21 |
| 2024-11-11 | 1.44M shares 10-Q · filed 2024-11-14 |
| 2024-08-07 | 1.44M shares 10-Q · filed 2024-08-09 |
| 2024-05-10 | 4.78M shares 10-Q · filed 2024-05-13 |
| 2024-04-16 | 4.78M shares 10-K/A · filed 2024-04-22 |
| 2024-03-15 | 4.31M shares 10-K · filed 2024-03-22 |
| 2023-11-06 | 3.94M shares 10-Q · filed 2023-11-09 |
| 2023-08-07 | 3.64M shares 10-Q · filed 2023-08-10 |
| 2023-05-05 | 2.49M shares 10-Q · filed 2023-05-11 |
| 2023-03-20 | 2.47M shares 10-K · filed 2023-03-27 |
| 2022-11-07 | 2.28M shares 10-Q · filed 2022-11-10 |
| 2022-08-01 | 56.12M shares 10-Q · filed 2022-08-05 |
| 2022-05-09 | 56.12M shares 10-Q · filed 2022-05-12 |
| 2022-03-18 | 46.70M shares 10-K · filed 2022-03-25 |
| 2021-11-01 | 45.21M shares 10-Q · filed 2021-11-04 |
| 2021-08-02 | 44.78M shares 10-Q · filed 2021-08-05 |
| 2021-05-10 | 44.77M shares 10-Q · filed 2021-05-12 |
| 2021-03-15 | 44.73M shares 10-K · filed 2021-03-18 |
| 2020-11-09 | 19.84M shares 10-Q · filed 2020-11-12 |
| 2020-08-07 | 19.82M shares 10-Q · filed 2020-08-12 |
| 2020-05-05 | 13.65M shares 10-Q/A · filed 2020-05-15 |
| 2020-03-16 | 13.67M shares 10-K · filed 2020-03-23 |
| 2019-11-11 | 4.07M shares 10-Q · filed 2019-11-12 |
| 2019-07-12 | 18.07M shares 10-Q · filed 2019-07-17 |
| 2019-04-26 | 18.07M shares 10-Q · filed 2019-05-01 |
| 2019-03-01 | 18.07M shares 10-K · filed 2019-03-06 |
| 2018-10-31 | 18.07M shares 10-Q · filed 2018-11-05 |
| 2018-07-27 | 18.07M shares 10-Q · filed 2018-08-01 |
| 2018-04-27 | 18.01M shares 10-Q · filed 2018-05-02 |
| 2018-03-02 | 17.97M shares 10-K · filed 2018-03-07 |
| 2017-11-03 | 17.97M shares 10-Q · filed 2017-11-06 |
| 2017-07-28 | 17.97M shares 10-Q · filed 2017-08-02 |
| 2017-04-28 | 17.97M shares 10-Q · filed 2017-05-03 |
| 2017-03-03 | 17.97M shares 10-K · filed 2017-03-08 |
| 2016-10-28 | 17.97M shares 10-Q · filed 2016-11-02 |
| 2016-07-29 | 17.97M shares 10-Q · filed 2016-08-03 |
| 2016-04-29 | 17.97M shares 10-Q · filed 2016-05-04 |
| 2016-03-04 | 17.95M shares 10-K · filed 2016-03-08 |
| 2015-10-30 | 17.94M shares 10-Q · filed 2015-11-04 |
| 2015-07-31 | 17.94M shares 10-Q · filed 2015-08-05 |
| 2015-04-30 | 17.93M shares 10-Q · filed 2015-05-06 |
| 2015-03-20 | 17.93M shares 10-K · filed 2015-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |